INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 39 filers reported holding INFLARX NV in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,321 | -76.1% | 132,658 | -64.3% | 0.00% | -100.0% |
| Q2 2023 | $1,655,155 | +438933.2% | 371,111 | +205.0% | 0.00% | – |
| Q4 2022 | $377 | -99.9% | 121,693 | -2.2% | 0.00% | – |
| Q3 2022 | $328,000 | +10.4% | 124,403 | -39.3% | 0.00% | – |
| Q2 2022 | $297,000 | -7.2% | 204,871 | +17.1% | 0.00% | – |
| Q1 2022 | $320,000 | +384.8% | 175,005 | +1162.3% | 0.00% | – |
| Q4 2021 | $66,000 | -44.5% | 13,864 | -69.9% | 0.00% | – |
| Q3 2021 | $119,000 | +22.7% | 46,080 | +41.6% | 0.00% | – |
| Q2 2021 | $97,000 | -18.5% | 32,542 | +6.6% | 0.00% | – |
| Q1 2021 | $119,000 | -74.9% | 30,515 | -74.6% | 0.00% | -100.0% |
| Q4 2019 | $475,000 | +19.9% | 120,070 | -25.2% | 0.00% | 0.0% |
| Q3 2019 | $396,000 | -85.7% | 160,521 | -81.7% | 0.00% | -75.0% |
| Q2 2019 | $2,774,000 | +96.5% | 877,824 | +2249.1% | 0.00% | +100.0% |
| Q1 2019 | $1,412,000 | -46.2% | 37,368 | -48.2% | 0.00% | -50.0% |
| Q4 2018 | $2,624,000 | +25.2% | 72,153 | +18.1% | 0.00% | +33.3% |
| Q3 2018 | $2,096,000 | +9.4% | 61,073 | +2.8% | 0.00% | +50.0% |
| Q2 2018 | $1,916,000 | +80.2% | 59,415 | +17.1% | 0.00% | +100.0% |
| Q4 2017 | $1,063,000 | – | 50,742 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 732,670 | $27,688,000 | 11.07% |
| Cormorant Asset Management, LP | 2,590,000 | $97,876,000 | 6.62% |
| RA Capital Management | 2,810,708 | $106,217,000 | 4.58% |
| Redmile Group, LLC | 2,182,638 | $82,482,000 | 2.41% |
| EMORY UNIVERSITY | 71,884 | $2,716,000 | 1.91% |
| Artal Group S.A. | 825,000 | $31,177,000 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 175,414 | $6,629,000 | 0.89% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,500 | $1,223,000 | 0.45% |
| Birchview Capital, LP | 16,000 | $605,000 | 0.38% |
| Eventide Asset Management | 275,000 | $10,392,000 | 0.36% |